Key result
Novel percutaneous indirect annuloplasty device achieves a ~1.2 mm reduction in septal-lateral mitral annular distance.
Why the study?
Percutaneous indirect annuloplasty has emerged for functional/ischemic mitral regurgitation, motivating evaluation of the feasibility of an indirect annuloplasty technique using a new device.
Does a novel percutaneous indirect annuloplasty device successfully reduce septal-to-lateral mitral annular distance and improve leaflet coaptation in an acute ovine model?
Does a novel percutaneous indirect annuloplasty device successfully reduce septal-to-lateral mitral annular distance and improve leaflet coaptation in an acute ovine model?
This preclinical study demonstrates the acute feasibility and anatomical efficacy of a novel transvenous indirect mitral annuloplasty device.
Answers are grounded in this paper and cite their sources.
Acute ovine feasibility does not inform clinical practice; leaves open translation to human mitral regurgitation.
Objectives: Percutaneous indirect annuloplasty has emerged as a treatment strategy for functional/ischemic mitral regurgitation. This study sought to evaluate the feasibility of percutaneous indirect annuloplasty technique using a new device. Methods: The device has 3 components: the "saddle" inserted into the great cardiac vein, the "plug" positioned in the left ventricular outflow tract, and the "bridge," a transatrial suture connecting the 2 holding elements. The aim was to shorten the septal-to-lateral distance of the mitral annulus by pulling on the saddle element. The procedure was performed through venous access in healthy adult sheep. A dedicated catheter holding a needle was used to deploy the saddle into the great cardiac vein and pierce its wall toward the left atrium to deploy the expanded polytetrafluoroethylene suture that is part of the bridge. A catheter for transseptal puncture was inserted for crossing the interatrial septum and piercing the aortic-mitral curtain, thereby allowing the plug to be deployed. The plug was held in place by the second part of the expanded polytetrafluoroethylene bridge. The 2 parts of the bridge were then joined to reduce the septal-to-lateral mitral annular distance. The septal-to-lateral distance and the coaptation length at P2 level were measured before and after the procedure using echocardiography. Results: Overall, 10 animals were treated, 7 successfully. The mean procedure duration was 110 ± 81 minutes. Septal-to-lateral distance decreased from 3.8 mm to 2.6 mm (30%), and maximum increase of mitral leaflet coaptation was 4 mm. Conclusions: This new approach seems promising for percutaneous treatment of functional mitral regurgitation.
No takes yet. Share an insight, caveat, or question.
Tozzi et al. (2022) studied Healthy animal model for mitral regurgitation (n=10). Percutaneous indirect annuloplasty device (saddle, plug, and bridge) vs. Baseline (pre-procedure measurements) was evaluated on Septal-to-lateral (SL) mitral annular distance (Mean difference -1.2 mm, p=<.001). The novel percutaneous indirect annuloplasty device successfully reduced the septal-to-lateral mitral annular distance from 3.8 mm to 2.6 mm in an acute healthy sheep model.
Synapse has enriched 10 related papers. Consider them for comparative context: